Inhibitory effect of alpinate Oxyphyllae fructus extracts on Ang II-induced cardiac pathological remodeling-related pathways in H9c2 cardiomyoblast cells

BioMedicine (Netherlands)

Volumn 3, Issue 4, 2013, Pages 148-152

  Chang, Yung Ming ^a,b   Velmurugan, Bharath Kumar ^a   Kuo, Wei Wen ^a   Chen, Yueh Sheng ^a   Ho, Tsung Jung ^a,c   Tsai, Chuan Te ^b   Ye, Chi Xin ^a   Tsai, Chang Hai ^d   Tsai, Fuu Jen ^a   Huang, Chih Yang ^a,d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b 1PT Biotechnology Co Ltd   (Taiwan)

^c CHINA MEDICAL UNIVERSITY BEIGANG HOSPITAL   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

Author keywords

Alpinate Oxyphyllae fructus; Ang II; G q; H9c2 cardiomyoblasts; Hypertrophy; IGF II

Indexed keywords

ALPINATE OXYPHYLLAE FRUCTUS EXTRACT; ANGIOTENSIN II; CALCINEURIN; PLANT EXTRACT; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG;

ALPINATE OXYPHYLLAE FRUCTUS; APOPTOSIS; ARTICLE; CELL PROTECTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOWN REGULATION; DRUG INHIBITION; FRUIT; HEART VENTRICLE HYPERTROPHY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPINIA OXYPHYLLA;

EID: 84888882958     PISSN: 22118020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomed.2013.05.001     Document Type: Article

References (34)

1. Vasan R.S., Beiser A., Seshadri S., Larson M.G., Kannel W.B., D'Agostino R.B., et al. Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study. JAMA 2002, 287:1003-1010.
2. Susic D., Frohlich E.D. The aging hypertensive heart: a brief update. Nat Clin Pract Cardiovasc Med 2008, 5:104-110.
3. Del Giudice A., Pompa G., Aucella F. Hypertension in the elderly. J Nephrol 2010, 23(Suppl. 15):S61-S71.
4. Yin G., Yan C., Berk B.C. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 2003, 35:780-783.
5. Cai H., Hu W., Dong Y. Changes of myocardial tissue and plasma angiotensin II in rats with pressure overload and effect of lujiao prescription. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000, 20:282-285.
6. Harrison D.G., Cai H., Landmesser U., Griendling K.K. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003, 4:51-61.
7. Billet S., Aguilar F., Baudry C., Clauser E. Role of angiotensin II AT1 receptor activation in cardiovascular diseases. Kidney Int 2008, 74:1379-1384.
8. Gonzalez A., Lopez B., Ravassa S., Querejeta R., Larman M., Diez J., et al. Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension 2002, 39:75-80.
9. Paton J.F., Wang S., Polson J.W., Kasparov S. Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med 2008, 86:705-710.
10. Diep Q.N., El Mabrouk M., Yue P., Schiffrin E.L. Effect of AT(1) receptor blockade on cardiac apoptosis in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 2002, 282:H1635-H1641.
11. Cheng X.W., Murohara T., Kuzuya M., Izawa H., Sasaki T., Obata K., et al. Superoxide-dependent cathepsin activation is associated with hypertensive myocardial remodeling and represents a target for angiotensin II type 1 receptor blocker treatment. Am J Pathol 2008, 173:358-369.
12. Kurikawa N., Suga M., Kuroda S., Yamada K., Ishikawa H. An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells. Br J Pharmacol 2003, 139:1085-1094.
13. Antus B., Mucsi I., Rosivall L. Apoptosis induction and inhibition of cellular proliferation by angiotensin II: possible implication and perspectives. Acta Physiol Hung 2000, 87:5-24.
14. Lopez J.J., Lorell B.H., Ingelfinger J.R., Weinberg E.O., Schunkert H., Diamant D., et al. Distribution and function of cardiac angiotensin AT1- and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994, 267:H844-H852.
15. Tsutsumi Y., Matsubara H., Ohkubo N., Mori Y., Nozawa Y., Murasawa S., et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998, 83:1035-1046.
16. Wharton J., Morgan K., Rutherford R.A., Catravas J.D., Chester A., Whitehead B.F., et al. Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. JPharmacol Exp Ther 1998, 284:323-336.
17. Widdop R.E., Jones E.S., Hannan R.E., Gaspari T.A. Angiotensin AT2 receptors: cardiovascular hope or hype?. Br J Pharmacol 2003, 140:809-824.
18. Filippatos G., Uhal B.D. Blockade of apoptosis by ACE inhibitors and angiotensin receptor antagonists. Curr Pharm Des 2003, 9:707-714.
19. De Mello W.C., Danser A.H. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 2000, 35:1183-1188.
20. de Cavanagh E.M., Ferder M., Inserra F., Ferder L. Angiotensin II, mitochondria, cytoskeletal, and extracellular matrix connections: an integrating viewpoint. Am J Physiol Heart Circ Physiol 2009, 296:H550-H558.
21. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998, 93:215-228.
22. Kang Y.J. Molecular and cellular mechanisms of cardiotoxicity. Environ Health Perspect 2001, 109(Suppl. 1):27-34.
23. Adams J.W., Pagel A.L., Means C.K., Oksenberg D., Armstrong R.C., Brown J.H. Cardiomyocyte apoptosis induced by Galphaq signaling is mediated by permeability transition pore formation and activation of the mitochondrial death pathway. Circ Res 2000, 87:1180-1187.
24. Adachi S., Ito H., Akimoto H., Tanaka M., Fujisaki H., Marumo F., et al. Insulin-like growth factor-II induces hypertrophy with increased expression of muscle specific genes in cultured rat cardiomyocytes. J Mol Cell Cardiol 1994, 26:789-795.
25. Chu C.H., Tzang B.S., Chen L.M., Liu C.J., Tsai F.J., Tsai C.H., et al. Activation of insulin-like growth factor II receptor induces mitochondrial-dependent apoptosis through G(alpha)q and downstream calcineurin signaling in myocardial cells. Endocrinology 2009, 150:2723-2731.
26. Chu C.H., Tzang B.S., Chen L.M., Kuo C.H., Cheng Y.C., Chen L.Y., et al. IGF-II/mannose-6-phosphate receptor signaling induced cell hypertrophy and atrial natriuretic peptide/BNP expression via Galphaq interaction and protein kinase C-alpha/CaMKII activation in H9c2 cardiomyoblast cells. J Endocrinol 2008, 197:381-390.
27. Chang M.H., Kuo W.W., Chen R.J., Lu M.C., Tsai F.J., Kuo W.H., et al. IGF-II/mannose 6-phosphate receptor activation induces metalloproteinase-9 matrix activity and increases plasminogen activator expression in H9c2 cardiomyoblast cells. J Mol Endocrinol 2008, 41:65-74.
28. Lee S.D., Chu C.H., Huang E.J., Lu M.C., Liu J.Y., Liu C.J., et al. Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation. Am J Physiol Endocrinol Metab 2006, 291:E306-E314.
29. Shi G.F., An L.J., Jiang B., Guan S., Bao Y.M. Alpinia protocatechuic acid protects against oxidative damage invitro and reduces oxidative stress invivo. Neurosci Lett 2006, 403:206-210.
30. Koo B.S., Lee W.C., Chang Y.C., Kim C.H. Protective effects of alpinae oxyphyllae fructus (Alpinia oxyphylla MIQ) water-extracts on neurons from ischemic damage and neuronal cell toxicity. Phytother Res 2004, 18:142-148.
31. Yu X., An L., Wang Y., Zhao H., Gao C. Neuroprotective effect of Alpinia oxyphylla Miq. fruits against glutamate-induced apoptosis in cortical neurons. Toxicol Lett 2003, 144:205-212.
32. An L.J., Guan S., Shi G.F., Bao Y.M., Duan Y.L., Jiang B. Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. Food Chem Toxicol 2006, 44:436-443.
33. Shui G., Bao Y.M., Bo J., An L.J. Protective effect of protocatechuic acid from Alpinia oxyphylla on hydrogen peroxide-induced oxidative PC12 cell death. Eur J Pharmacol 2006, 538:73-79.
34. Shoji N., Umeyama A., Takemoto T., Ohizumi Y. Isolation of a cardiotonic principle from Alpinia oxyphylla. Planta Med 1984, 50:186-187.